DERIVATIVE COMPOUNDS OF CARBOXYLIC ACID AND AGENTS COMPRISING THEREOF AS ACTIVE COMPONENTS Russian patent published in 2007 - IPC C07D413/14 C07D263/32 C07D417/04 C07D417/10 C07D413/04 C07D413/10 A61K31/55 A61K31/421 A61K31/496 A61K31/433 A61K31/422 A61K31/5377 A61K31/4523 A61K31/4427 

Abstract RU 2296760 C2

FIELD: organic chemistry, medicine, pharmacy.

SUBSTANCE: invention relates to derivative compound of carboxylic acid represented by the formula (I): , wherein each X and Y represents independently (C1-C4)-alkylene; Z means -O-; each R1, R2, R3 and R4 means independently hydrogen atom or (C1-C8)-alkyl; R5 means (C2-C8)-alkenyl; A means -O- or -S-; D means D1, D2, D3, D4 or D5 wherein D1 means (C1-C8)-alkyl; D2 means compound of the formula: wherein ring 1 represents saturated 6-membered monoheteroaryl comprising one nitrogen atom and, optionally, another one heteroatom chosen from oxygen, sulfur and nitrogen atoms; D3 means compound of the formula: wherein ring 2 represents (1) completely saturated (C3-C10)-monocarboxylic aryl, or (2) optionally saturated 5-membered monoheteroaryl comprising 3 atoms chosen from nitrogen and sulfur atoms, or completely saturated 6-membered monoheteroaryl comprising 1 heteroatom representing oxygen atom; D4 means compound of the formula: ; D5 means compound of the formula: ; R6 represents (1) hydrogen atom, (2) (C1-C8)-alkyl, (3) -NR7R8 wherein R7 or R8 represent hydrogen atom or (C1-C8)-alkyl, or R7 and R8 taken in common with nitrogen atom to which they are added form saturated 5-6-membered monoheteroaryl comprising one nitrogen atom and, optionally, another one heteroatom representing oxygen atom; E means -CH or nitrogen atom; m means a whole number 1-3, or its nontoxic salt. Invention relates to a regulator activated by peroxisome proliferator receptor, agent used in prophylaxis and/or treatment of diseases associated with metabolism disorders, such as diabetes mellitus, obesity, syndrome X, hypercholesterolemia or hyperlipoproteinemia, hyperlipidemia, atherosclerosis, hypertension, diseases coursing with circulation disorder, overeating or heart ischemic disease, and to an agent that increases cholesterol level associated with HDL, reduces cholesterol level associated with LDL and/or VLDL, eliminates risk factor in development of diabetes mellitus and/or syndrome X and comprising a compound represented by the formula (I) or its nontoxic salt as an active component and a carrier, excipient or solvent optionally. Invention proposes derivative compounds of carboxylic acid possessing the modulating activity with respect to peroxisome proliferator receptor (PPAR).

EFFECT: valuable medicinal properties of compounds.

15 cl, 5 tbl, 48 ex

Similar patents RU2296760C2

Title Year Author Number
DIHYDRONAPHTHALENE DERIVATIVES AND MEDICINAL AGENT COMPRISING INDICATED DERIVATIVES AS ACTIVE COMPONENT 2001
  • Tadzima Khisao
  • Nakajama Josisuke
  • Fukusima Dajkiti
RU2268262C2
DERIVATIVES OF CARBOXYLIC ACIDS AND PHARMACEUTICAL AGENT COMPRISING THEIR AS ACTIVE COMPONENT 2002
  • Tani Kosuke
  • Asada Masaki
  • Kobajasi Kaoru
  • Narita Masami
  • Ogava Mikio
RU2315746C2
PIPERIDINE DERIVATIVES AND AGENT COMPRISING PIPERIDINE DERIVATIVE AS ACTIVE COMPONENT 2001
  • Nakai Khisao
  • Kisikava Katsuja
RU2275359C2
DERIVATIVE OF CARBOXYLIC ACID, PHARMACEUTICAL COMPOSITION AND MEDICINE OF PREVENTING AND/OR CURING DISEASES, CAUSED BY ACTIVATION OF DP RECEPTOR, USE OF SUCH DERIVATIVE FOR MAKING SUCH MEDICINE, METHOD OF PREVENTING AND/OR CURING DISEASES, CAUSED BY ACTIVATION OF DP RECEPTORS 2003
  • Ivakhasi Maki
  • Kobajasi Kaoru
  • Nambu Fumio
RU2329256C2
PHENYLACETIC ACID DERIVATIVE AND ITS USE 2004
  • Kusuda Sinija
  • Nakajama Josisuke
  • Tadzima Khisao
  • Sakamoto Takakhiko
RU2349587C2
COMPOUND CAPABLE OF BONDING WITH S1P RECEPTOR AND PHARMACEUTICAL APPLICATION THEREOF 2004
  • Nakade Sindzi
  • Mizuno Khirotaka
  • Ono Takedzi
  • Minami Masasi
  • Saga Khirosi
  • Khagija Khirosi
  • Komija Takaki
  • Khabasita Khiromu
  • Kurata Kharuto
  • Okhtsuki Kazukhiro
  • Kusumi Kensuke
RU2390519C2
HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL AGENT BASED ON THEREOF AND METHOD OF TREATMENT 2002
  • Matsui Khirosi
  • Kobajasi Khideo
  • Azukizava Satoru
  • Kasai Masajasu
  • Josimi Akikhisa
  • Sirakhase Khiroaki
RU2299197C2
PHARMACEUTICAL COMPOSITIONS FOR TREATMENT DISEASES ASSOCIATED WITH REDUCING OSSEOUS MASS AND COMPRISING EP AGONIST AS ACTIVE COMPONENT 2002
  • Marujama Toru
  • Kobajasi Kaoru
  • Kambe Tokhru
  • Marujama Takajuki
  • Josida Khidejuki
  • Nisiura Akio
  • Abe Nobutaka
RU2303451C2
8-AZAPROSTAGLANDINE DERIVATIVES, PHARMACEUTICAL COMPOSITION AND AGENT FOR PROPHYLAXIS OF DISEASES 2003
  • Tani Kousuke
  • Kobajasi Kaoru
  • Marujama Toru
  • Kambe Tokhru
  • Ogava Mikio
  • Siroja Tsutomu
RU2306309C2
OXAZOLE DERIVATIVES SUBSTITUTED WITH CARBOXYLIC ACIDS AS PPAR-ALPHA AND PPAR-GAMMA ACTIVATORS IN DIABETES TREATMENT 2002
  • Binggeli Al'Fred
  • Beringer Markus
  • Greter Uve
  • Khil'Pert Khans
  • Mehrki Khans-Peter
  • Mejer Markus
  • Mor Peter
  • Riklen Fab'En
RU2278859C2

RU 2 296 760 C2

Authors

Tadzima Khisao

Nakajama Esisuke

Dates

2007-04-10Published

2002-11-11Filed